Document Detail


Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.
MedLine Citation:
PMID:  8727434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. DESIGN: Prospective, clinical study using sequential periods. SETTING: A 12-bed surgical intensive care unit in a university hospital. PATIENTS: 14 patients with sepsis syndrome and 15 patients with septic shock treated with exogenous catecholamines were studied. They had no diuretic treatment. INTERVENTION: Two periods of 2 h each with and without 2 micrograms.kg-1.min-1 of dopamine infusion. Hemodynamic and renal data were obtained at the end of each period. Measurements were repeated after 48 h of dopamine infusion in patients with sepsis syndrome. All data were evaluated by the Wilcoxon rank test. MEASUREMENTS AND RESULTS: In patients with sepsis syndrome, diuresis and creatinine clearance increased significantly by 100% and 60%, respectively, during low-dose dopamine infusion without any change in systemic hemodynamics. The renal response to dopamine decreased significantly after 48 h of dopamine infusion (P < 0.01). In patients with septic shock treated with catecholamines, no variation of either systemic hemodynamics or renal function was noted during low-dose dopamine infusion. CONCLUSION: The renal effects of low-dose dopamine in patients with sepsis syndrome decrease with time. No renal effect of low-dose dopamine was observed in patients with septic shock treated with catecholamines. These findings suggest a desensitization of renal dopaminergic receptors.
Authors:
T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Related Documents :
2249834 - Respiratory tract pathology in patients with severe burns.
10340734 - Comparison of four drugs for local treatment of burn wounds.
16795264 - The punishment of persistent vomiting: a case study.
22396364 - Variations between two 24-hour urine collections in patients presenting to a tertiary s...
3998914 - Wegener granulomatosis in pediatric patients.
3896964 - Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Intensive care medicine     Volume:  22     ISSN:  0342-4642     ISO Abbreviation:  Intensive Care Med     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-09-18     Completed Date:  1996-09-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  213-9     Citation Subset:  IM    
Affiliation:
Departement d'Anesthésie-Réanimation, Hôpital Antoine Béclère, Université Paris-Sud, Clamart, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Dopamine / administration & dosage,  therapeutic use*
Hemodynamics / drug effects
Humans
Infusions, Intravenous
Kidney / drug effects*
Middle Aged
Prospective Studies
Shock, Septic / drug therapy*,  physiopathology
Statistics, Nonparametric
Survival Analysis
Systemic Inflammatory Response Syndrome / drug therapy*,  physiopathology
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Computed tomography vs clinical and multidisciplinary procedures for early evaluation of severe abdo...
Next Document:  Assessment of gastric acidity in intensive care patients: intermittent pH registration cannot replac...